Radar on Drug Benefits

Biosimilars Get Call-Out in PBMs’ 2nd Quarter Earnings Calls

Despite experiencing medical cost trends during the second quarter of 2021 that were much less favorable than they were a year ago, publicly traded health insurers during their recent earnings calls were eager to to...
0 Comments
© 2024 MMIT

Humana/Anthem PBM Venture Could Attract More Blues Plans

Humana Inc. and Anthem, Inc. are teaming up with hedge fund administrator SS&C Technologies Holdings, Inc. to create DomaniRx, a new joint venture that aims to offer a “best-in-class” PBM cloud-based claims ...
0 Comments
© 2024 MMIT

News Briefs

✦ AARP launched a seven-figure, digital ad campaign on July 19 aimed at pressing Congress to support actions to lower drug prices, The Hill reported. The campaign will appear in The New York Times, The Washington ...
0 Comments
© 2024 MMIT

Navitus Debuts Predictive Tool To Prevent Opioid Misuse

COVID-19 presented the health care system with many challenges in 2020, but one of the most sobering was the impact on opioid misuse. The Centers for Disease Control and Prevention (CDC) said earlier this month t...
0 Comments
© 2024 MMIT

Medicare ‘Overspent’ by 20% Compared With Costco Prices on Generic Drugs

Medicare spent $2.6 billion more on 184 most common generic drugs compared with Costco member prices for the same prescriptions in 2018, according to a recent research letter published in JAMA Internal Medicine. By ...
0 Comments
© 2024 MMIT

Senate Will Likely Decide Fate of Drug Pricing, PBM Reforms

Even as Congress inches closer to passing the largest individual spending bill in U.S. history through budget reconciliation, health care insiders are still uncertain what drug pricing measures could make their way ...
0 Comments
© 2024 MMIT

News Briefs

✦ Eli Lilly & Co. is making a direct equity investment in MiNA Therapeutics Limited, a company that describes itself as “the pioneer in small activating RNA therapeutics.” Lilly’s investment of $15 milli...
0 Comments
© 2024 MMIT

Prime Therapeutics Rolls Out New Medical Benefit Offering

As payers continue to look for ways to tackle the rising spending on specialty drugs, Prime Therapeutics LLC is launching a medical drug management program. Known as MedDrive, the offering will be rolled out in pha...
0 Comments
© 2024 MMIT

Generic Drug Prices Vary Significantly Across Hospitals

In an effort to increase transparency, CMS now requires hospitals to provide pricing information for all medications and services. A recent GoodRx analysis of 12 common generic medications in 16 hospitals found that...
0 Comments
© 2024 MMIT

Cell/Gene Therapy Pay Models Face Reporting, Policy Barriers

Emerging cell and gene therapy oncology treatments are well suited to value-based payment arrangements, but new contracting models must be able to contend with a complex regulatory and financial environment, experts...
0 Comments
© 2024 MMIT